In addition, loss of RIP3 expression has also been observed in primary colon cancer tissue, primary breast cancer tissue, most acute myeloid leukemia samples and chronic lymphocytic leukemia.12–14 These reports indicate that RIP3 deficiency could be associated with cancer development and progression. This evidence concerns the gene RIPK3 and breast carcinoma.